Thomas S Harrison Selected Research

Antigens

1/2023	Cryptococcal Antigenemia in Advanced Human Immunodeficiency Virus Disease: Pathophysiology, Epidemiology, and Clinical Implications.
1/2022	Outcomes of flucytosine-containing combination treatment for cryptococcal meningitis in a South African national access programme: a cross-sectional observational study.
1/2021	Cryptococcal Antigen in Serum and Cerebrospinal Fluid for Detecting Cryptococcal Meningitis in Adults Living With Human Immunodeficiency Virus: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies.
1/2021	Establishing targets for advanced HIV disease: A call to action.
12/2020	Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease.
11/2020	Genome-Wide Association Study Identifies Novel Colony Stimulating Factor 1 Locus Conferring Susceptibility to Cryptococcosis in Human Immunodeficiency Virus-Infected South Africans.
10/2020	Cryptococcal-related Mortality Despite Fluconazole Preemptive Treatment in a Cryptococcal Antigen Screen-and-Treat Program.
10/2020	Cryptococcal Meningitis Screening and Community-based Early Adherence Support in People With Advanced Human Immunodeficiency Virus Infection Starting Antiretroviral Therapy in Tanzania and Zambia: A Cost-effectiveness Analysis.
1/2019	Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
10/2018	High Cryptococcal Antigen Titers in Blood Are Predictive of Subclinical Cryptococcal Meningitis Among Human Immunodeficiency Virus-Infected Patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas S Harrison Research Topics

Disease

64	Cryptococcal Meningitis 01/2024 - 05/2004
14	Infections 12/2023 - 02/2005
8	Cryptococcosis 02/2024 - 05/2004
7	Meningoencephalitis 12/2022 - 02/2010
6	Tuberculosis (Tuberculoses) 01/2023 - 02/2010
5	Meningitis 12/2020 - 03/2007
4	Mycoses (Diseases, Fungus) 12/2022 - 01/2003
4	Body Weight (Weight, Body) 01/2022 - 03/2007
3	HIV Infections (HIV Infection) 10/2020 - 05/2015
3	Aneuploidy (Aneuploid) 12/2019 - 01/2018
3	Immune Reconstitution Inflammatory Syndrome 10/2018 - 06/2010
3	Anemia 01/2018 - 01/2012
3	Hypokalemia 01/2017 - 01/2012
2	Pulmonary Tuberculosis 09/2023 - 10/2014
2	Acquired Immunodeficiency Syndrome (AIDS) 12/2018 - 01/2017
2	Headache (Headaches) 10/2018 - 10/2018
2	Ototoxicity 01/2017 - 08/2011
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2017 - 08/2011
2	Neutropenia 12/2015 - 02/2010
1	Thrombophlebitis 10/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	COVID-19 01/2021
1	Chromosome Duplication 12/2019
1	Autoimmune Diseases (Autoimmune Disease) 12/2018
1	Neoplasms (Cancer) 12/2018
1	Fever (Fevers) 10/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2018
1	Extensively Drug-Resistant Tuberculosis 01/2017
1	Hearing Loss (Hearing Impairment) 01/2017
1	Vitamin D Deficiency 08/2014
1	Inflammation (Inflammations) 01/2014
1	Central Nervous System Diseases (CNS Diseases) 01/2013
1	Invasive Fungal Infections 08/2012
1	Aspergillosis 11/2009
1	Mannose-Binding Protein Deficiency 11/2009

Drug/Important Bio-Agent (IBA)

29	Fluconazole (Zonal)FDA LinkGeneric 01/2023 - 05/2004
20	Flucytosine (Ancobon)FDA Link 01/2023 - 05/2004
18	AntigensIBA 01/2023 - 08/2005
18	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2022 - 05/2004
10	liposomal amphotericin B FDA Link 01/2023 - 07/2013
7	deoxycholate drug combination amphotericin BIBA 01/2023 - 07/2013
3	Antifungal AgentsIBA 06/2022 - 06/2013
3	Capsules (Microcapsules)IBA 01/2018 - 09/2006
3	InterferonsIBA 01/2014 - 06/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2014 - 09/2006
2	Rifampin (Rifampicin)FDA LinkGeneric 09/2023 - 10/2014
2	chinese inkIBA 01/2022 - 10/2018
2	rifapentine (Priftin)FDA Link 01/2019 - 10/2014
2	Proteins (Proteins, Gene)FDA Link 10/2018 - 01/2017
2	Amikacin (A.M.K)FDA LinkGeneric 01/2017 - 08/2011
2	Capreomycin (Capastat)FDA Link 01/2017 - 08/2011
2	ElectrolytesIBA 01/2017 - 12/2015
2	CreatinineIBA 12/2015 - 01/2012
2	CytokinesIBA 04/2015 - 02/2005
2	EnzymesIBA 11/2009 - 01/2003
1	Transcription Factors (Transcription Factor)IBA 12/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	AzolesIBA 12/2022
1	Biomarkers (Surrogate Marker)IBA 06/2022
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2021
1	Macrophage Colony-Stimulating FactorIBA 11/2020
1	lipoarabinomannan (LAM)IBA 07/2020
1	RifamycinsIBA 01/2019
1	CarbonIBA 12/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2018
1	dimemorfan (AT 17)IBA 10/2018
1	Nonsense Codon (Nonsense Mutation)IBA 01/2017
1	FluoroquinolonesIBA 01/2017
1	ChemokinesIBA 04/2015
1	Genetic Markers (Genetic Marker)IBA 01/2015
1	Moxifloxacin (Avelox)FDA Link 10/2014
1	Ethambutol (Myambutol)FDA LinkGeneric 10/2014
1	Pyrazinamide FDA LinkGeneric 10/2014
1	Isoniazid (Ftivazide)FDA LinkGeneric 10/2014
1	hydroxide ionIBA 08/2014
1	25-hydroxyvitamin DIBA 08/2014
1	LaccaseIBA 05/2014
1	Interleukin-7 (Interleukin 7)IBA 01/2014
1	Interleukin-8 (Interleukin 8)IBA 01/2014
1	InterleukinsIBA 01/2014
1	Voriconazole (Vfend)FDA LinkGeneric 01/2012
1	Saline SolutionIBA 01/2012
1	PotassiumIBA 01/2012
1	LipidsIBA 02/2010
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 11/2009
1	Pattern Recognition ReceptorsIBA 11/2009
1	Complement System Proteins (Complement)IBA 11/2009
1	ImmunosorbentsIBA 11/2009
1	Interferon-gamma (Interferon, gamma)IBA 09/2009
1	Interleukin-10 (Interleukin 10)IBA 03/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2007

Therapy/Procedure

46	Therapeutics 01/2024 - 05/2004
5	Art Therapy 10/2021 - 01/2013
3	Immunotherapy 11/2020 - 06/2012
2	Aftercare (After-Treatment) 02/2024 - 01/2017
2	Injections 01/2017 - 08/2011
1	Cannula 10/2022
1	Duration of Therapy 01/2017
1	Immunomodulation 04/2015